Diets · Metabolic & Cardiometabolic
high dietary omega-6:omega-3 ratio causes chronic inflammation and cardiometabolic disease
In plain terms: Is a high ratio of omega-6 to omega-3 fats bad for your heart and inflammation?
Part of: 🔍 seed oils
Mainstream evidence does not support the ratio as a useful risk marker: higher omega-6/linoleic-acid biomarkers track LOWER heart disease and mortality, and controlled trials show no rise in inflammation, so the ratio hypothesis leans against the harm thesis.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
The evidence (10)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Bjermo 2012 · Am J Clin Nutr | RCT | contradicts | high | Raising n-6 PUFA (worsening ratio) did not increase inflammatory markers in humans, undercutting the ratio-inflammation mechanism. |
| Marventano 2015 · Int J Food Sci Nutr | observational | mixed | moderate | Review finds omega-3 generally beneficial but the few studies using the n-6:n-3 RATIO give contrasting results; ratio not a robust predictor. |
| Ferro CJ 2026 · Clin Kidney J | observational | tested-null | low | Reviews omega-3 PUFA pleiotropic effects in CKD/dialysis and the PISCES trial (1.6g EPA + 0.8g DHA daily, n=1228 hemodialysis patients), which found a 43% reduction in cardiovascular events with absolute high-dose fish oil supplementation. Frames benefit entir |
| Powers CD 2026 · Curr Dev Nutr | observational | tested-null | moderate | NHANES cross-sectional data (n=7213) show 54% of the US population has an undesirably low Omega-3 Index (RBC EPA+DHA), which is strongly correlated with sudden cardiac death risk; the paper frames risk purely via absolute erythrocyte omega-3 levels, not a rati |
| Ramsden 2010 · Br J Nutr | meta-analysis | mixed | moderate | Meta-analysis found n-6-specific (not mixed n-3/n-6) PUFA diets did not reduce and may raise CHD risk, implicating absolute n-3, not the ratio per se. |
| Farvid 2014 · Circulation | meta-analysis | contradicts | high | Meta-analysis of 13 cohorts (310,602 people): higher dietary linoleic acid linked to 15% lower CHD events and 21% lower CHD death, dose-responsive. |
| Marklund 2019 · Circulation | observational | contradicts | high | Individual-level pooled 30-cohort biomarker analysis: higher linoleic acid associated with lower CVD and total mortality, not higher. |
| Hamley 2017 · Nutr J | meta-analysis | contradicts | moderate | Meta-analysis of diet-heart RCTs found replacing SFA with n-6 PUFA gave no clear CHD benefit once confounders removed, undercutting simple ratio arguments. |
| Harris 2009 · Circulation | observational | contradicts | high | AHA science advisory: omega-6 PUFA intake of 5-10% energy lowers CHD risk; explicitly rejects the omega-6:omega-3 ratio as a useful concept. |
| Messina 2021 · Nutrition | observational | contradicts | moderate | Review: soybean oil (largest US omega-6 source) lowers cholesterol and CHD risk with no effect on inflammation or oxidation markers; health agencies reject the ratio. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.